SB Investment Advisers (uk) Ltd., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 226,198 shares at $6.05 ($1.4M) on 2025-10-27, disclosed to the SEC on 2025-10-28.
Scheduled sale ($1.4M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.96 | 46,696 | $278K | 20.5% |
| 2 | $5.96 | 46,696 | $278K | 20.5% |
| 3 | $6.05 | 66,403 | $402K | 29.5% |
| 4 | $6.05 | 66,403 | $402K | 29.5% |
| Total | $6.01 avg | 226,198 | $1.4M | 100% |
| Filing → |
| VIR | SELL | 2025-10-09 | $6.4M | — | Filing → |
| CPNG | SELL | 2025-06-17 | $282.5M | — | Filing → |
| CPNG | SELL | 2025-05-12 | $772.5M | — | Filing → |